|
| Status |
Public on Jul 01, 2019 |
| Title |
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
31478830 |
| |
| Submission date |
Apr 01, 2019 |
| Last update date |
Sep 11, 2019 |
| Contact name |
David D Schlaepfer |
| E-mail(s) |
dschlaepfer@ucsd.edu
|
| Phone |
858822344
|
| Organization name |
UCSD
|
| Department |
Moores Cancer Center
|
| Lab |
Gynecologic Oncology
|
| Street address |
3855 Health Sciences Dr.
|
| City |
La Jolla |
| State/province |
CA |
| ZIP/Postal code |
92093 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (20)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE129097 |
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy [ID8 and ID8-IP / KMF cells] |
| GSE129098 |
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy [KMF parental, KMF clone KT13 (FAK-/-), KT13 + GFP-FAK, KT13 + GFP-FAK R454, and KT13 + deltaGSK beta-catenin] |
|
| Relations |
| BioProject |
PRJNA530129 |
Less...
More...